MARKHAM, ON, July 20, 2018 /CNW/ - MedReleaf Corp.
("MedReleaf") (TSX: LEAF) today announced that the Ontario Superior
Court of Justice (Commercial List) has issued a final order
approving its previously announced plan of arrangement (the
"Arrangement") pursuant to which Aurora Cannabis Inc. ("Aurora")
agreed to acquire all of the issued and outstanding common shares
of MedReleaf for 3.575 common shares of Aurora and $0.000001 in cash in exchange for each MedReleaf
common share held.
The closing of the Arrangement remains subject to certain
customary closing conditions. Assuming the timely satisfaction of
these closing conditions, the Arrangement is expected to close on
or about July 25, 2018.
Shareholders who have questions or require assistance with
submitting their shares to the Arrangement, including with respect
to completing the applicable letter of transmittal, are asked to
contact Computershare Investor Services Inc., who is acting as
depositary under the Arrangement, toll free at 1-800-564-6253 or by
email at corporateactions@computershare.com.
About MedReleaf
Canada's most awarded licensed
producer, MedReleaf is an R&D-driven company dedicated to
innovation, operational excellence and the production of industry
leading, top-quality cannabis. Sourced from around the world and
carefully cultivated in one of two state-of-the-art ICH-GMP and ISO
9001 certified facilities in Ontario, with a third facility currently in
development, a full range of premium MedReleaf products are
delivered to the global medical market. We serve the therapeutic
needs of patients seeking safe, consistent and effective medical
cannabis and provide a compelling product offering for the
adult-use recreational market.
For more information on MedReleaf, its products, research and
how the company is helping patients #livefree, please visit
MedReleaf.com or follow @medreleaf.
Forward-Looking Statements
CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS: Certain
information in this news release constitutes forward-looking
statements under applicable securities laws. Any statements that
are contained in this news release that are not statements of
historical fact may be deemed to be forward-looking statements.
Forward looking statements are often identified by terms such as
"may", "should", "anticipate", "expect", "potential", "believe",
"intend" or the negative of these terms and similar expressions.
Forward looking statements in this news release include, but are
not limited to, statements with respect to the timing for the
completion of the Arrangement and the satisfaction of closing
conditions. There can be no assurance that the Arrangement will be
completed. Forward looking statements are based on certain
assumptions. While MedReleaf considers these assumptions to be
reasonable, based on information currently available, they may
prove to be incorrect. Readers are cautioned not to place undue
reliance on forward-looking statements.
SOURCE MedReleaf Corp.